CHOU2 PHARMA
Flipping the script on pet cannabinoid science
Flipping the script on pet cannabinoid science
CHOU2 PHARMA is revolutionizing pet cannabinoid science with the mission of bridging the gap in pet care for vets and pet owners. The company offers pet cannabinoid products crafted using the Cannolation Purification System™, setting a new standard for ingredient purity, dosage accuracy, safety, and effectiveness. Their science and education-driven approach ensures that the products specifically target pets' needs. Founded in 2021 and headquartered in the United States, CHOU2 PHARMA's commitment to innovation in the Health Care industry presents a compelling investment opportunity. As of now, the company is drawing attention from potential investors, while its products are available for purchase at chou2pharma.com.
There is no investment information
No recent news or press coverage available for CHOU2 PHARMA.
We care about your data, and we'd love to use cookies make your experience better.
